NSE: DEEPAKNTR · 9 November 2026
- Deepak Nitrite Ltd. (DEEPAKNTR) moved down by 0.75% on November 9, 2026, settling at ₹1,540.0 after opening at ₹1,559.6. The stock traded within a day's range of ₹1,535.0 to ₹1,564.0, showing mild intraday downward pressure from its previous close of ₹1,551.7.
- Deepak Nitrite reported its highest-ever quarterly and first-half performance for the period ended September 30, 2026. Consolidated total income for Q2 FY27 reached ₹3,091 crore, up 61% year-on-year, while EBITDA surged 187% year-on-year to ₹643 crore and PAT rose 235% year-on-year to ₹398 crore. For H1 FY27, total income stood at ₹5,682 crore with an EBITDA of ₹1,197 crore, propelled primarily by record performance in the Phenolics segment.
- Trading volume was 0.21 times the 20-day average daily volume.
Why is Deepak Nitrite share price falling on 9 November 2026?
Deepak Nitrite Ltd. (DEEPAKNTR) moved down by 0.75% on November 9, 2026, settling at ₹1,540.0 after opening at ₹1,559.6. The stock traded within a day's range of ₹1,535.0 to ₹1,564.0, showing mild intraday downward pressure from its previous close of ₹1,551.7.
In relative market context, the stock's modest pullback contrasted slightly with broader market indices on November 9, 2026. The Nifty benchmark edged up marginally by 0.06%, while the sectoral benchmark, Nifty Metal, slipped 0.11%. Deepak Nitrite's performance reflects ongoing consolidation, extending a wider recent trend where the stock has declined by 5.05% over the past 20 trading days, despite a minor 0.57% recovery over the preceding 5 trading days.
The current price action occurs against the backdrop of the company's record-breaking financial performance reported for Q2 and H1 FY2027 on October 29, 2026, where consolidated total income surged 61% year-on-year to ₹3,091 crore and EBITDA jumped 187% year-on-year to ₹643 crore, driven by exceptional momentum in the Phenolics segment. While these robust earnings provide strong fundamental context, today's negative price move appears more aligned with short-term consolidation and lack of a fresh same-day catalyst rather than any company-specific operational setback.
95,306 shares traded by 9 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 4.50 lakh shares (0.21 times). The five-day average daily volume was 3.26 lakh shares. Separately, the NSE report for 9 November 2026 showed 47,710 shares delivered, representing 50.06% of that day’s traded volume. The same report recorded 9,518 trades.
With no new same-day operational triggers or announcements, the 0.75% decline appears to reflect routine intraday consolidation and low relative trading volume following a 20-day pullback of 5.05%.
Latest Company Developments
Deepak Nitrite reported its highest-ever quarterly and first-half performance for the period ended September 30, 2026. Consolidated total income for Q2 FY27 reached ₹3,091 crore, up 61% year-on-year, while EBITDA surged 187% year-on-year to ₹643 crore and PAT rose 235% year-on-year to ₹398 crore. For H1 FY27, total income stood at ₹5,682 crore with an EBITDA of ₹1,197 crore, propelled primarily by record performance in the Phenolics segment.
Demonstrates exceptional earnings expansion and validates the company's integrated manufacturing and backward integration strategies.
Deepak Chem Tech Limited, a wholly owned subsidiary of Deepak Nitrite, successfully commissioned its chlorination and specialty chemical plant along with utilities and infrastructure at Dahej, Gujarat. The total capital expenditure incurred for the project reached approximately ₹300 crores as of commencement.
Expands the manufacturing footprint and long-term production capacity in specialized chemical segments.
Deepak Chem Tech Limited issued and allotted 80,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) of face value ₹100 each, aggregating to ₹80 crores, to Deepak Phenolics Limited, another wholly owned subsidiary.
Strengthens the capital base of the subsidiary to support ongoing project expenses and general corporate purposes.
General Updates- Q2 & H1 FY2027 Results Presentation.
Cessation of Dileep Choksi as Non- Executive Independent Director of the company effective. August 07, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 11.98% on 30 September 2026. This compares with 11.45% on 30 June 2026, a change of +0.53 percentage points.
The filing reported 24 MF/UTI holders.
What to Watch Next
- Execution progress and commercial ramp-up of the newly commissioned chlorination and specialty plant at Dahej.
- Sustained margin trends and raw material cost pass-through capability in the Advanced Intermediates and Phenolics segments.
- Delivery volume trends and institutional participation relative to the 20-day average volume.
- Post-earnings management commentary regarding demand visibility and channel inventory normalization.
Other Dated Coverage
More Deepak Nitrite news and dated analysis →
Frequently Asked Questions
What is the latest Deepak Nitrite company news?
Deepak Nitrite reported its highest-ever quarterly and first-half performance for the period ended September 30, 2026. Consolidated total income for Q2 FY27 reached ₹3,091 crore, up 61% year-on-year, while EBITDA surged 187% year-on-year to ₹643 crore and PAT rose 235% year-on-year to ₹398 crore. For H1 FY27, total income stood at ₹5,682 crore with an EBITDA of ₹1,197 crore, propelled primarily by record performance in the Phenolics segment.
How strong was Deepak Nitrite’s trading volume?
95,306 shares traded, 0.21 times the 20-day average daily volume. The price and volume data are dated 9 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.